This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (151)
Death (48)
Life Threatening Events (19)
Disability (4)
Reports by Reaction Type
Febrile Neutropenia (30),
Nausea (21),
Respiratory Failure (15),
Pleural Effusion (14),
Sepsis (12),
Death (11),
Hypotension (11),
Interstitial Lung Disease (10),
Pneumonia (10),
Therapeutic Response Decreased (10),
Diarrhoea (10),
Insomnia (10)
Below are a few examples of reports where side effects / adverse reactions may be related to Mozobil (Plerixafor Subcutaneous). For a complete list or a specific selection of reports, please use the links above.
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: female, weighing 69.1 kg (152.0 pounds)
Reactions: Abdominal Pain, Vomiting, Pneumonia, Nausea, Pain, Orthostatic Hypotension, Headache, Hypoaesthesia, Constipation, Rash Pruritic, Paraesthesia, Fatigue, Insomnia, Dizziness, Decreased Appetite
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Zyrtec; Senna; Etoposide; Cytarabine; Fiberall; Demerol; Vitamin B Complex CAP; Compazine; Fiber Pills; Magnesium; Mitoxantrone; Sodium Chloride; Dexamethasone; Levothyroxine Sodium; Flonase; Benadryl; Ativan; Celexa; Estrogen NOS; Oxycodone HCL; Demerol; Multi-Vitamin; Colace; Neupogen; Allopurinol; Albuterol; Chlordiazepoxide W; Imipramine HCL; Vitamin E; Vitamin D; Zofran
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-22
Patient: female
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Indication: Lymphoma Transformation
Mozobil
Dosage: 15.36 mg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-04-27
End date: 2011-04-29
Other drugs received by patient: Neupogen; Terbinafine HCL; Centyl MED Kaliumklorid; Acyclovir
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Mozobil side effects in male
Reported by a physician from Denmark on 2012-08-20
Patient: male, weighing 119.0 kg (261.8 pounds)
Reactions: C-Reactive Protein Increased, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Levothyroxine Sodium; Aspirin; Neupogen Novum; Pantoprazole; Simvastatin; Metoprolol Succinate
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: female, weighing 91.1 kg (200.4 pounds)
Reactions: Cellulitis, Nausea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Voriconazole; Etoposide; Piperacillin W; Ondansetron; Hydrocortisone; Neupogen; Dilaudid; Tylenol-500; Linezolid; Cytarabine; Mitoxantrone; Benadryl
Possible Mozobil side effects in 59 year old female
Reported by a physician from United States on 2012-08-20
Patient: 59 year old female, weighing 58.9 kg (129.6 pounds)
Reactions: White Blood Cell Count Decreased, Blood Bilirubin Increased, Jaundice, Hepatic Function Abnormal, Haematuria, Alanine Aminotransferase Increased, Cystitis, Fatigue, Diarrhoea, Aspartate Aminotransferase Increased, Platelet Count Decreased, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluconazole
Dosage: unk
Indication: Antifungal Treatment
End date: 2012-07-24
Mozobil
Dosage: unk, 2 cycles
Indication: Acute Myeloid Leukaemia
Neupogen
Dosage: unk, 2 cycles
Indication: Acute Myeloid Leukaemia
Sorafenib
Dosage: unk, 2 cycles
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Antibacterial NOS; Antivirals NOS
Possible Mozobil side effects in male
Reported by a physician from France on 2012-08-17
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Bone Pain
Drug(s) suspected as cause:
Granocyte
Dosage: 430 mcg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-22
End date: 2012-02-22
Mozobil
Dosage: 15840 mcg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-22
End date: 2012-02-22
Other drugs received by patient: Morphine; Oxycodone Hydrochloride; Nefopam; Cytarabine; Daunorubicin HCL
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-17
Patient: male, weighing 72.6 kg (159.7 pounds)
Reactions: Acute Myeloid Leukaemia, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Clofarabine
Dosage: 37 mg, qd
Start date: 2012-02-02
End date: 2012-02-05
Clofarabine
Dosage: 37 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 17.4 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 17.4 mg, qd
Start date: 2012-02-01
End date: 2012-02-04
Vancomycin
Dosage: 1 g, bid
Indication: Sepsis
Start date: 2012-02-05
End date: 2012-02-07
Other drugs received by patient: Daunorubicin HCL; Potassium Chloride; Nicotine; Fluticasone Propionate / Salmeterol; Acetaminophen and Codeine Phosphate; Ondansetron; Potassium Chloride; Allopurinol; Daunorubicin HCL; Cyclizine; Furosemide; Ipratropium Bromide; Chlordiazepoxide; Itraconazole; Acyclovir; Meropenem; Meropenem; Acetaminophen and Codeine Phosphate; Calcium Carbonate; Daunorubicin HCL
Possible Mozobil side effects in male
Reported by a physician from France on 2012-08-17
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2050 mg, qd, days 8-10
Start date: 2012-04-26
End date: 2012-04-28
Cytarabine
Dosage: 1050 mg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Daunorubicin HCL
Dosage: 125 mg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Granocyte
Dosage: 410 mcg, qd, days 1-10
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-28
Mozobil
Dosage: 240 mcg/kg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Mozobil
Dosage: 240 mcg/kg, qd, days 8-10
Start date: 2012-04-26
End date: 2012-04-28
Mozobil
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09
Patient: female, weighing 44.0 kg (96.8 pounds)
Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Meropenem; Etoposide; Cytarabine; Acetaminophen; Morphine Sulfate; Ondansetron; Vancomycin; Solutions FOR Parenteral Nutrition
Possible Mozobil side effects in male
Reported by a physician from United States on 2012-08-07
Patient: male
Reactions: Cerebral Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
End date: 2012-07-25
Mozobil
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: female, weighing 85.9 kg (189.0 pounds)
Reactions: White Blood Cell Count Decreased, Acute Myeloid Leukaemia, Pulmonary Alveolar Haemorrhage, Febrile Neutropenia, Lung Infection Pseudomonal, Pseudomonal Bacteraemia, Multi-Organ Failure, Respiratory Failure, Platelet Count Decreased, Cardiac Arrest, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen; Carvedilol; Cefpodoxime Proxetil; Polyethylene Glycol; Valacyclovir Hydrochloride; Furosemide; Fluconazole; Temazepam; Fluticasone W; Tramadol HCL; Lansoprazole; Nifedipine; Nifedipine; Docusate Sodium W; Ondansetron Hydrochloride; Potassium Chloride; Levothyroxine Sodium; Sorafenib; Heparin; Lisinopril
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: female
Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Cytarabine; Morphine Sulfate; Ondansetron; Etoposide; Solutions FOR Parenteral Nutrition; Vancomycin; Acetaminophen; Meropenem
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Sepsis, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Lorazepam; Mitoxantrone; Morphine Sulfate; Neupogen; Etoposide; Cytarabine; Hydrocodone Bitartrate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-07-20
Patient: female, weighing 69.1 kg (152.0 pounds)
Reactions: Abdominal Pain, Pneumonia, Vomiting, Nausea, Pain, Orthostatic Hypotension, Hypoaesthesia, Headache, Constipation, Paraesthesia, Rash Pruritic, Fatigue, Insomnia, Dizziness, Decreased Appetite
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Mitoxantrone; Celexa; Fiberall; Vitamin B Complex CAP; Multi-Vitamin; Colace; Benadryl; Allopurinol; Albuterol; Imipramine HCL; Zyrtec; Demerol; Vitamin D; Neupogen; Dexamethasone; Oxycodone HCL; Magnesium Sulfate; Etoposide; Sodium Chloride; Ativan; Flonase; Cytarabine; Chlordiazepoxide W; Estrogen NOS; Senna-Mint WAF; Zofran; Fiber Pills; Vitamin E; Levothyroxine Sodium; Demerol; Compazine
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19
Patient: female
Reactions: White Blood Cell Count Decreased, Atelectasis, Pneumonia, Platelet Count Decreased, Febrile Neutropenia, Pulmonary Fibrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen; Sorafenib
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-07-17
Patient: female
Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Cytarabine; Meropenem; Ondansetron; Vancomycin; Etoposide; Acetaminophen; Morphine Sulfate; Solutions FOR Parenteral Nutrition
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-07-17
Patient: female, weighing 91.1 kg (200.4 pounds)
Reactions: Cellulitis, Nausea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Etoposide; Linezolid; Ondansetron; Voriconazole; Hydrocortisone; Mitoxantrone; Neupogen; Dilaudid; Cytarabine; Piperacillin W; Acetaminophen; Benadryl
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient: female, weighing 92.1 kg (202.6 pounds)
Reactions: Myalgia, Vomiting, Nausea, Diarrhoea, Hypotension, Oedema, Headache
Drug(s) suspected as cause:
Mozobil
Dosage: 52000 mcg, unk
Start date: 2011-11-10
End date: 2011-11-10
Mozobil
Dosage: 52000 mcg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-09
End date: 2011-11-09
Mozobil
Dosage: 52000 mcg, unk
Start date: 2011-11-11
End date: 2011-11-14
Other drugs received by patient: Neupogen; Mitoxantrone; Cytarabine; Hydrochlorothiazide; Etoposide; Citalopram Hydrobromide; Lisinopril; Multi-Vitamin; Klor-CON
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin
Possible Mozobil side effects in 74 year old female
Reported by a physician from United States on 2012-07-11
Patient: 74 year old female, weighing 67.6 kg (148.7 pounds)
Reactions: Atelectasis, Hyperglycaemia, Hypotension, General Physical Health Deterioration, Hypercalcaemia, Ascites, Diarrhoea, Decubitus Ulcer, Urinary Tract Infection Bacterial, Dehydration, Hypomagnesaemia, Pleural Effusion, Splenic Haemorrhage, Diffuse Large B-Cell Lymphoma, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Filgrastim
Dosage: 570 mcg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-02-01
Mozobil
Dosage: 22840 mcg, qd
Start date: 2012-01-31
End date: 2012-02-01
Mozobil
Dosage: 22840 mcg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 13704 mcg, once
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-01-25
Other drugs received by patient: Vitamin D; Heparin Lock-Flush; Magic Mouthwash; HP Supplement; Miralax; Steroid Therapy; Fluorodeoxyglucose F 18; Oxycodone HCL; Oxycodone HCL; Acetaminophen; Furosemide; Calcium Citrate; Potassium Chloride; Colace
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-09
Patient: male
Reactions: White Blood Cell Count Decreased, Fatigue, Anaemia, Chest Pain, Peritonsillar Abscess, Pyrexia, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: unk
Indication: Acute Leukaemia
Start date: 2012-04-20
Daunorubicin HCL
Dosage: unk
Indication: Acute Leukaemia
Start date: 2012-04-20
Mozobil
Dosage: unk
Indication: Acute Leukaemia
Start date: 2012-04-20
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Sepsis, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Etoposide; Cytarabine; Mitoxantrone; Hydrocodone; Neupogen; Morphine; Lorazepam
Possible Mozobil side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 65 year old male
Reactions: Arrhythmia Supraventricular, Blood Pressure Systolic Decreased, Dyspnoea, Hypothermia, Hyperkalaemia, Anaemia, Ascites, Chronic Lymphocytic Leukaemia, Pleural Effusion, Thrombocytopenia, Asthenia, White Blood Cell Count Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Acyclovir; Pantoprazole; Simvastatin; Prochlorperazine; Tamsulosin HCL; Lenalidomide; Hydrocodone W; Temazepam; Trimethoprim + Sulfamethoxazole
Possible Mozobil side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 56 year old male
Reactions: Sepsis, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Mitoxantrone; Cytarabine; Granulocyte Colony Stimulating Factor; Etoposide
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29
Patient: male, weighing 72.6 kg (159.7 pounds)
Reactions: Acute Myeloid Leukaemia, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Clofarabine
Dosage: 37 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Clofarabine
Dosage: 37 mg, qd
Start date: 2012-02-02
End date: 2012-02-05
Mozobil
Dosage: 17.4 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 17.4 mg, qd
Start date: 2012-02-01
End date: 2012-02-04
Vancomycin
Dosage: 1 g, bid
Indication: Sepsis
Start date: 2012-02-05
End date: 2012-02-07
Other drugs received by patient: Itraconazole; Meropenem; Meropenem; Ondansetron; Cyclizine; Daunorubicin HCL; Fluticasone Propionate / Salmeterol; Daunorubicin HCL; Acyclovir; Potassium Chloride; Allopurinol; Calcium Carbonate; Furosemide; Ipratropium Bromide; Nicotine; Acetaminophen and Codeine Phosphate; Potassium Chloride; Daunorubicin HCL; Acetaminophen and Codeine Phosphate; Chlordiazepoxide
|